Mining Press Releases
SEE OTHER BRANDS

Keeping up with mining news from the world

Mining Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mining Press Releases.

Press releases published on August 7, 2025

The Joint Corp. Reports Second Quarter 2025 Financial Results

The Joint Corp. Reports Second Quarter 2025 Financial Results

- Refranchised 37 clinics; Franchises now represent 92% of the portfolio - - Acquired rights to the Northwest regional developer territory - SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, …

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Phase 2b NAVIGATE clinical trial evaluating CD388 for the prevention of seasonal influenza met primary and all secondary efficacy endpoints for all dose groups End of Phase 2 meeting request submitted to the U.S. Food and Drug Administration (FDA) Closed …

Health Catalyst Reports Second Quarter 2025 Results

Health Catalyst Reports Second Quarter 2025 Results

SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended …

Progyny, Inc. Announces Second Quarter 2025 Results

Progyny, Inc. Announces Second Quarter 2025 Results

Reports Record Revenue of $332.9 Million, Reflecting 9.5% Growth Generates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance to Reflect Continued Increase in Pacing of Member …

Dorchester Minerals, L.P. Announces Second Quarter Results

Dorchester Minerals, L.P. Announces Second Quarter Results

DALLAS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today the Partnership’s net income for the quarter ended June 30, 2025 of $12,347,000, or $0.25 per common unit. A comparison of the Partnership …

Key Tronic Corporation Announces Fourth Quarter Reporting and Annual Meeting Date

Key Tronic Corporation Announces Fourth Quarter Reporting and Annual Meeting Date

SPOKANE VALLEY, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Key Tronic Corporation (Nasdaq: KTCC), announced today that it plans to report its results for the fourth quarter and full year ended of fiscal 2025 after market close on August 27, 2025. Key Tronic …

scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Generated net FUROSCIX® revenue of $16 million in the second quarter of 2025; up 99% over Q2 2024 Doses shipped to patients increased 45% over Q1 2025 and 117% over Q2 2024 Launch of FUROSCIX in chronic kidney disease Autoinjector remains on track for sNDA …

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025

$60.0M in 2Q25 Total Product Revenue More than 100 Patients Treated with Amtagvi® in 2Q25 Strategic Restructuring Extends Cash Runway into 4Q26 FY25 Total Product Revenue Guidance of $250M-$300M Reiterated SAN CARLOS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) …

ThreeSixty Journalism Concludes 2025 Storytelling Institute for Local Students

ThreeSixty Journalism Concludes 2025 Storytelling Institute for Local Students

ST. PAUL, Minn., Aug. 07, 2025 (GLOBE NEWSWIRE) -- ThreeSixty Journalism has successfully concluded its 2025 Multimedia Storytelling Institute, a three-week summer camp held July 7 through July 24 at the University of St. Thomas College of Arts and …

EXP’s Expansion marks first milestone by joining SR 400 Peach Partners in financial close of Georgia SR 400 Express Lanes Project

EXP’s Expansion marks first milestone by joining SR 400 Peach Partners in financial close of Georgia SR 400 Express Lanes Project

ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- EXP, a global engineering, architecture, design and consulting firm, recently established a new infrastructure sector led by business development leader and Senior Vice President Kyle Henry. The new sector, …

Galapagos Creates New Subscription Right Plan

Galapagos Creates New Subscription Right Plan

Mechelen, Belgium; August 7, 2025, 22.01 CET; regulated information – Galapagos NV (Euronext …

Galapagos creëert nieuw inschrijvingsrechtenplan

Galapagos creëert nieuw inschrijvingsrechtenplan

Mechelen, België; 7 augustus 2025, 22.01 CET; gereglementeerde informatie – Galapagos NV (Euronext …

Celldex Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Celldex Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Strong execution and continued progress across pipeline Unprecedented data delivered from Phase 2 CSU study demonstrating profound, sustained complete response and improved quality of life 7 months after completion of barzolvolimab dosing Data anticipated …

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

Q2 revenue of $29.2 million, increased 55% year-over-year Q2 gross profit increased 59% year-over-year to $18.6 million Paid down $4.5 million of principal on outstanding term loan during Q2 Increased full year 2025 guidance to a revenue range between $104 …

Skye Bioscience Reports Second Quarter 2025 Financial Results and Business Update

Skye Bioscience Reports Second Quarter 2025 Financial Results and Business Update

Reiterate top-line data readout from CBeyond™ Phase 2a study of nimacimab planned late Q3/early Q4 2025 Patient enrollment in Skye’s CBeyondTM Phase 2a obesity trial extension study initiated Independent Data Safety Monitoring Committee completed fourth …

Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results

Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results

Announced positive topline results from registrational STAAR study in Fabry disease, including positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed patients in the study, which U.S. Food and Drug …

CompoSecure Reports Record Second Quarter 2025 Financial Results

CompoSecure Reports Record Second Quarter 2025 Financial Results

Operating results exceed expectations across all key metrics Strong top line growth driven by domestic programs from traditional banks and fintechs Record profitability demonstrates early results from CompoSecure Operating System Raising previously issued …

Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025

Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025

PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, …

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2025 Financial Results

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2025 Financial Results

Soquelitinib data from cohort 3 of atopic dermatitis Phase 1 clinical trial demonstrates earlier and deeper responses compared to cohorts 1-2 along with clinically meaningful reduction in itch as early as day 8 Enrollment ongoing in Phase 1 trial extension …

Apyx Medical Corporation Reports Second Quarter 2025 Financial Results

Apyx Medical Corporation Reports Second Quarter 2025 Financial Results

Successfully launched AYON Body Contouring System™ to key surgeons in critical geographies; plan for commercial launch in September 2025 Initiated commercial sales of Renuvion® in China with strong clinical interest and completed initial procedures Based …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions